---
category: news
title: "'Cutting-edge science': OCD drug designed by artificial intelligence"
excerpt: "Two pharmaceutical companies have embarked on a brave new world, having begun human testing for the first time on a drug treatment for obsessive-compulsive disorder designed by artificial intelligence. British startup Exscientia and Japanâ€™s Sumitomo Dainippon Pharma used artificial intelligence to create the drug in less than 12 months ..."
publishedDateTime: 2020-02-07T03:34:00Z
webUrl: "https://www.washingtontimes.com/news/2020/feb/6/exscientia-ocd-drug-designed-artificial-intelligen/"
type: article
quality: 39
heat: 39
published: false

provider:
  name: Washington Times
  domain: washingtontimes.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://twt-thumbs.washtimes.com/media/image/2020/02/06/AP639348897898_c0-216-5184-3240_s1200x700.jpg?48c42b2789ee0d08ce9a91ab8317603cc81a12f8"
    width: 1200
    height: 700
    title: "'Cutting-edge science': OCD drug designed by artificial intelligence"

secured: "hBWT5IK6afMPJz9eQcaCeUzM1s7qrOGG/500bv8Td6ZrDk3WoG59KyBw9jiH2wwzXJa+pp7nSjj6IEoTLGy6CCVwPP2vhwaomzzj/ny3YyXTpY45avRcIzdwxB1/oul1lfbYKkuHBCgqXIrzGC3bvmQfF1VeOByg2T33yFrC4+2sF00Brfxe2es4NmvnH5Vk1RBCH9NwEcxfYXgnJ4rwem4zf8xsnTIF/35HgQPuf2OVm7ix23H9Yx1lFL0xNvk28VAG8kao9ssJa3/Wbm4E5gtUkFobfH1e0fnnB6FCvq4i/eNkSbAteTaoDnVWhLMu;4UkcXPXMEOxYipsI+gCUAQ=="
---

